First Patient Given Gene Therapy for Sanfilippo Syndrome Type A

Abeona Therapeutics announced that the first patient in a Phase 1/2 trial for ABO-102, a single treatment gene therapy strategy for patients with Sanfilippo syndrome Type A has been given the therapy at Nationwide Children’s Hospital.